METHYLSCREEN

Welcome to the Brand page for “METHYLSCREEN”, which is offered here for Medical diagnostic test kits comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in genomics, pharmacogenomics, life sciences, pharmaceuticals, the diagnosis of disease, such as cancer, metabolic disorders, psychiatric disorders, age-related disorders central nervous system and infectious diseases; agriculture diagnostic test kits comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology and breeding; veterinary diagnostic test kit comprised of enzymes, nucleic acids, and chemicals for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology, genomics, and breeding; microbiological diagnostic test kit for the detection of methylation patterns and differentiation of methylation patterns associated with specific phenotypes for use in biotechnology, genomics, homeland security, and biodefense;methyl screen;.

Its status is currently believed to be active. Its class is unavailable. “METHYLSCREEN” is believed to be currently owned by “Orion Genomics, LLC”.